Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Herbal International is a prominent pharmaceutical brand and global distributor specializing in modernized Traditional Chinese Medicine (TCM) and nutraceutical products. Operating primarily as the international face of top-tier Chinese manufacturers such as Jinzhou Jiutai Pharmaceutical and Guangdong Yifang Pharmaceutical (part of the Sinopharm Group), the company focuses on the standardization and global export of high-quality herbal therapies. Its portfolio centers on modernized TCM formula granules and patent medicines like Pudilan Anti-inflammatory Tablets and Xiaoshuan Tongluo, which are produced using advanced extraction and concentration technologies. The company maintains rigorous quality standards, with its products often being GMP-certified and TGA-approved for markets in Australia, Singapore, and across Asia. Herbal International aims to integrate ancient herbal wisdom into modern evidence-based healthcare through state-of-the-art manufacturing and research.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Herbal International.